SARASOTA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare services fertility company focused on expanding access to ...
Investors might want to bet on Invo BioScience Inc. (INVO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
INVO Fertility Inc IVF shares are surging Friday afternoon following a pair of key operational and regulatory milestones disclosed in a new SEC Form 8-K filing. Here’s what investors need to know.
Invo reports $1.38 million in quarterly sales, representing a 396.15% increase over sales of $278,140 from the same period last year. The company says it remains on-track with its goal of reaching ...
23% revenue growth, elimination of all Series C-2 Preferred Stock and warrant liabilities, and a strengthened balance sheet Growth reflects both organic clinic initiatives and acquisition contribution ...
INVO Fertility, Inc. (NASDAQ: IVF) reported Monday that an institutional investor exercised its Additional Investment Right to acquire 200 shares of the company’s Series C-2 Convertible Preferred ...
INVO Bioscience (NASDAQ:INVO) shares are trading higher on Monday after the company announced it signed binding agreements to acquire Wisconsin Fertility Institute. The purchase price of the ...
INVO's Board strengthened with independent directors as we enter a new growth trajectory for the Company Mr. Szot also serves on the board of directors and as Chairman of the Audit Committee of ...
Valued at less than $54 million in market capitalization, and with total annual sales barely passing the $1 million mark, Sarasota, Florida-based INVO Bioscience (INVO) is hardly a household name -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results